The store will not work correctly when cookies are disabled.
4-amino-1-(biphenyl-2-yl)-5-chloropyrimidin-2(1H)-one
ID: ALA4436811
PubChem CID: 155144946
Max Phase: Preclinical
Molecular Formula: C16H12ClN3O
Molecular Weight: 297.75
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(=O)n(-c2ccccc2-c2ccccc2)cc1Cl
Standard InChI: InChI=1S/C16H12ClN3O/c17-13-10-20(16(21)19-15(13)18)14-9-5-4-8-12(14)11-6-2-1-3-7-11/h1-10H,(H2,18,19,21)
Standard InChI Key: BCBGEFABBHZRRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
14.1082 -19.6123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1082 -20.4373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8202 -20.8456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5323 -20.4373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5323 -19.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8202 -19.1956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8202 -18.3707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2479 -19.2018 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.3943 -20.8508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8197 -21.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1036 -22.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1033 -22.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8183 -23.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5352 -22.9022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5319 -22.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2424 -21.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9583 -22.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6712 -21.6630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6694 -20.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9487 -20.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2388 -20.8430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
5 8 1 0
2 9 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
3 10 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
15 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.75 | Molecular Weight (Monoisotopic): 297.0669 | AlogP: 3.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 60.91 | Molecular Species: ┄ | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.95 | CX LogD: 2.95 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: -0.48 |
References
1. Chua GNL, Wassarman KL, Sun H, Alp JA, Jarczyk EI, Kuzio NJ, Bennett MJ, Malachowsky BG, Kruse M, Kennedy AJ.. (2019) Cytosine-Based TET Enzyme Inhibitors., 10 (2): [PMID:30783500] [10.1021/acsmedchemlett.8b00474] |